185 related articles for article (PubMed ID: 37770480)
1. Metabolic crosstalk between skeletal muscle cells and liver through IRF4-FSTL1 in nonalcoholic steatohepatitis.
Guo S; Feng Y; Zhu X; Zhang X; Wang H; Wang R; Zhang Q; Li Y; Ren Y; Gao X; Bian H; Liu T; Gao H; Kong X
Nat Commun; 2023 Sep; 14(1):6047. PubMed ID: 37770480
[TBL] [Abstract][Full Text] [Related]
2. Targeting Follistatin like 1 ameliorates liver fibrosis induced by carbon tetrachloride through TGF-β1-miR29a in mice.
Xu XY; Du Y; Liu X; Ren Y; Dong Y; Xu HY; Shi JS; Jiang D; Xu X; Li L; Xu ZH; Geng Y
Cell Commun Signal; 2020 Sep; 18(1):151. PubMed ID: 32933544
[TBL] [Abstract][Full Text] [Related]
3. Diet and exercise reduce pre-existing NASH and fibrosis and have additional beneficial effects on the vasculature, adipose tissue and skeletal muscle via organ-crosstalk.
van den Hoek AM; de Jong JCBC; Worms N; van Nieuwkoop A; Voskuilen M; Menke AL; Lek S; Caspers MPM; Verschuren L; Kleemann R
Metabolism; 2021 Nov; 124():154873. PubMed ID: 34478753
[TBL] [Abstract][Full Text] [Related]
4. Dynamic resistance exercise increases skeletal muscle-derived FSTL1 inducing cardiac angiogenesis via DIP2A-Smad2/3 in rats following myocardial infarction.
Xi Y; Hao M; Liang Q; Li Y; Gong DW; Tian Z
J Sport Health Sci; 2021 Sep; 10(5):594-603. PubMed ID: 33246164
[TBL] [Abstract][Full Text] [Related]
5. FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2.
Rao J; Wang H; Ni M; Wang Z; Wang Z; Wei S; Liu M; Wang P; Qiu J; Zhang L; Wu C; Shen H; Wang X; Cheng F; Lu L
Gut; 2022 Dec; 71(12):2539-2550. PubMed ID: 35140065
[TBL] [Abstract][Full Text] [Related]
6. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
[TBL] [Abstract][Full Text] [Related]
7. Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder.
Hu J; Wang H; Li X; Liu Y; Mi Y; Kong H; Xi D; Yan W; Luo X; Ning Q; Wang X
Theranostics; 2020; 10(21):9702-9720. PubMed ID: 32863955
[No Abstract] [Full Text] [Related]
8. Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice.
Kim KH; Kim SH; Han DH; Jo YS; Lee YH; Lee MS
Sci Rep; 2018 May; 8(1):6789. PubMed ID: 29717162
[TBL] [Abstract][Full Text] [Related]
9. The BMP antagonist follistatin-like 1 is required for skeletal and lung organogenesis.
Sylva M; Li VS; Buffing AA; van Es JH; van den Born M; van der Velden S; Gunst Q; Koolstra JH; Moorman AF; Clevers H; van den Hoff MJ
PLoS One; 2011; 6(8):e22616. PubMed ID: 21826198
[TBL] [Abstract][Full Text] [Related]
10. Aerobic exercise training-induced follistatin-like 1 secretion in the skeletal muscle is related to arterial stiffness via arterial NO production in obese rats.
Inoue K; Fujie S; Horii N; Yamazaki H; Uchida M; Iemitsu M
Physiol Rep; 2022 May; 10(10):e15300. PubMed ID: 35585770
[TBL] [Abstract][Full Text] [Related]
11. DIP2A functions as a FSTL1 receptor.
Ouchi N; Asaumi Y; Ohashi K; Higuchi A; Sono-Romanelli S; Oshima Y; Walsh K
J Biol Chem; 2010 Mar; 285(10):7127-34. PubMed ID: 20054002
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of Fstl1 attenuates hepatic stellate cell activation through the TGF‑β1/Smad3 signaling pathway.
Shang H; Liu X; Guo H
Mol Med Rep; 2017 Nov; 16(5):7119-7123. PubMed ID: 28901425
[TBL] [Abstract][Full Text] [Related]
13. c-Met Signaling Protects from Nonalcoholic Steatohepatitis- (NASH-) Induced Fibrosis in Different Liver Cell Types.
Drescher HK; Schumacher F; Schenker T; Baues M; Lammers T; Hieronymus T; Trautwein C; Streetz KL; Kroy DC
Oxid Med Cell Longev; 2018; 2018():6957497. PubMed ID: 30538805
[TBL] [Abstract][Full Text] [Related]
14. FSTL1 Secreted by Activated Fibroblasts Promotes Hepatocellular Carcinoma Metastasis and Stemness.
Loh JJ; Li TW; Zhou L; Wong TL; Liu X; Ma VWS; Lo CM; Man K; Lee TK; Ning W; Tong M; Ma S
Cancer Res; 2021 Nov; 81(22):5692-5705. PubMed ID: 34551961
[TBL] [Abstract][Full Text] [Related]
15. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
Tølbøl KS; Kristiansen MN; Hansen HH; Veidal SS; Rigbolt KT; Gillum MP; Jelsing J; Vrang N; Feigh M
World J Gastroenterol; 2018 Jan; 24(2):179-194. PubMed ID: 29375204
[TBL] [Abstract][Full Text] [Related]
16. Endogenous Follistatin-like 1 guarantees the immunomodulatory properties of mesenchymal stem cells during liver fibrotic therapy.
Zheng X; Zhou X; Ma G; Yu J; Zhang M; Yang C; Hu Y; Ma S; Han Z; Ning W; Jin B; Zhou X; Wang J; Han Y
Stem Cell Res Ther; 2022 Aug; 13(1):403. PubMed ID: 35932064
[TBL] [Abstract][Full Text] [Related]
17. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Harris SE; Poolman TM; Arvaniti A; Cox RD; Gathercole LL; Tomlinson JW
Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G345-G360. PubMed ID: 32755310
[TBL] [Abstract][Full Text] [Related]
18. Follistatin-like 1 in vertebrate development.
Sylva M; Moorman AF; van den Hoff MJ
Birth Defects Res C Embryo Today; 2013 Mar; 99(1):61-9. PubMed ID: 23723173
[TBL] [Abstract][Full Text] [Related]
19. FSTL1 as a Potential Mediator of Exercise-Induced Cardioprotection in Post-Myocardial Infarction Rats.
Xi Y; Gong DW; Tian Z
Sci Rep; 2016 Aug; 6():32424. PubMed ID: 27561749
[TBL] [Abstract][Full Text] [Related]
20. FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis.
Liu C; Schönke M; Spoorenberg B; Lambooij JM; van der Zande HJP; Zhou E; Tushuizen ME; Andreasson AC; Park A; Oldham S; Uhrbom M; Ahlstedt I; Ikeda Y; Wallenius K; Peng XR; Guigas B; Boon MR; Wang Y; Rensen PCN
Elife; 2023 Jan; 12():. PubMed ID: 36648330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
